US Broker Ratings

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Potential 127% Upside

Investors looking into the biotechnology sector may find Fulcrum Therapeutics, Inc. (NASDAQ: FULC) an intriguing prospect, given its substantial potential upside of 127.54% based on current analyst price targets. With..

National Research Corporation (NRC) Investor Outlook: Evaluating High Dividend Yield Amidst Revenue Decline

National Research Corporation (NRC), a U.S.-based leader in health information services, offers investors a compelling mix of high dividend yield and challenges in revenue growth. With a market capitalization of..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 118% Potential Upside

Investors with an eye on the biotechnology sector may find Benitec Biopharma Inc. (BNTC) an intriguing prospect, especially given its substantial potential upside of 118.45%. At its current price of..

Quantum-Si Incorporated (QSI): Investor Outlook on a Medical Device Innovator with 176% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI) presents a compelling case for investors seeking opportunities in the burgeoning field of medical devices, particularly in the innovative realm of Next Generation Protein Sequencing (NGPS)...

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Biotech Path with a Market Cap of $4.68 Billion

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotech sector with a market capitalization of $4.68 billion, catching the attention of investors eager to explore the potential of precision..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unveiling a 72.8% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has emerged as a promising player in the biotechnology sector, captivating investors with its robust pipeline and strategic partnerships. With a market capitalization of $537.82..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 168% Potential Upside in the Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its intriguing position in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Closer Look at Its 10.20% Dividend Yield and 14.29% Potential Upside

Investors in the healthcare sector looking for steady income might find Spok Holdings, Inc. (NASDAQ: SPOK) an intriguing option, particularly given its robust dividend yield and notable potential upside. With..

TotalEnergies SE (TTE) Investor Outlook: Analyzing Potential and Performance with a 5.08% Dividend Yield

TotalEnergies SE (NYSE: TTE) is a formidable player in the energy sector, operating across a wide spectrum of energy sources, from traditional oil and gas to renewables and low-carbon hydrogen...

Nano-X Imaging Ltd (NNOX): Investor Outlook Highlights Stunning 179% Upside Potential

Nano-X Imaging Ltd (NASDAQ: NNOX), a pioneering company in the healthcare sector, is making waves with its promising potential upside, capturing the attention of both seasoned and novice investors. As..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential

MiMedx Group, Inc (MDXG), a key player in the biotechnology industry, stands at a compelling juncture for those eyeing promising investment opportunities in the healthcare sector. Based in the United..

Harrow, Inc. (HROW) Stock Analysis: A 31.79% Upside in the Healthcare Sector Beckons Investors

Harrow, Inc. (HROW) has been making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.98 billion, this Nashville-based pharmaceutical..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention

BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Known for its innovative contributions to the cell and gene..

Teladoc Health, Inc. (TDOC) Stock Analysis: A Look at the 41% Potential Upside for Investors

Teladoc Health, Inc. (NYSE: TDOC) stands as a prominent player in the rapidly evolving healthcare sector, specifically within the health information services industry. Headquartered in New York, the company offers..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 55.92% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. As a prominent player in the diagnostics and research industry, NeoGenomics operates a network..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 59.63% Upside as Analysts Stay Bullish

AtriCure, Inc. (NASDAQ: ATRC) stands at a compelling juncture for investors seeking opportunities in the healthcare sector. This Ohio-based company, specializing in medical instruments and supplies, is pivotal in developing..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Potential Upside of 38% Attracts Investor Attention

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company specializing in the development, manufacture, and sale of generic and proprietary injectable, inhalation, and intranasal products, presents a compelling opportunity for investors..

The Pennant Group, Inc. (PNTG): Investor Outlook Reveals 11.87% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a notable player in the healthcare sector, specifically within the medical care facilities industry, has recently captured investor attention with an enticing potential upside..

agilon health, inc. (AGL) Investor Outlook: Assessing a 54.75% Potential Upside Amidst Challenging Metrics

As agilon health, inc. (NYSE: AGL) continues to navigate the complexities of the healthcare sector, individual investors are drawn to the intriguing potential upside of 54.75% based on analyst target..

10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings

10x Genomics, Inc. (NASDAQ: TXG), a leading player in the healthcare sector, particularly in health information services, is making waves with its innovative solutions for biological system analysis. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds